Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Increased Risk of HF and AF in Patients With FH

Atherosclerosis; 2017 Nov; Hovland, Mundal, et al

Patients with familial hypercholesterolemia (FH) have twice the risk of hospitalization for heart failure (HF) or atrial fibrillation (AF) compared to those without FH, a recent study found. The study included 4,273 genotyped FH patients (51.7% women) with a total observational period of 18,300 patient years and estimated incidence rates of hospitalization for HF and AF. Researchers found:

  • Overall, the expected number of FH patients with HF was 27.7 and the observed number of cases was 54.
  • The highest excess risk was observed in those aged 25-49 years.
  • The total expected number of FH patients with AF was 39.4 while the observed number of cases was 77.
  • Among FH patients with an incident HF event, ~90% had a previous diagnosis of coronary artery disease (CAD), and ~40% had had a myocardial infarction.

Citation:

Hovland A, Mundal LJ, Igland J, et al. Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia. Atherosclerosis. 2017;266:69-73. doi:10.1016/j.atherosclerosis.2017.09.027.

This Week's Must Reads

Lipid Testing After Acute Myocardial Infarction, J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Clinical Pharmadynamics of Evolocumab, Clin Pharmacokinet; ePub 2018 Jan 20; Kasichayanula, et al

Lipoproteins & CV Outcomes in Dialysis Patients, J Clin Lipidol; ePub 2017 Dec 26; Kaysen, et al

Is Dual Lipid-Lowering Therapy Better?, Atherosclerosis; 2018 Feb; Gragnano, et al

sLOX-1 in Ischemic Stroke & Transient Ischemic Attack, J Am Heart Assoc; ePub 2018 Jan 12; Skarpengland, et al

Must Reads in Hypercholesterolemia

Lipid Testing After Acute Myocardial Infarction, J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Clinical Pharmadynamics of Evolocumab, Clin Pharmacokinet; ePub 2018 Jan 20; Kasichayanula, et al

Lipoproteins & CV Outcomes in Dialysis Patients, J Clin Lipidol; ePub 2017 Dec 26; Kaysen, et al

Is Dual Lipid-Lowering Therapy Better?, Atherosclerosis; 2018 Feb; Gragnano, et al

sLOX-1 in Ischemic Stroke & Transient Ischemic Attack, J Am Heart Assoc; ePub 2018 Jan 12; Skarpengland, et al